Academician
BANU İSKENDER İZGİ
Doçent
Kocaeli Üniversitesi Tıp Fakültesi Temel Tıp Bilimleri Bölümü
- Ana Dal Sağlık Bilimleri Temel Alanı
- Yan Dal Tıbbi Biyoloji
Citation impact
OpenAlex YÖKSİS articles matched in OpenAlex: 1 + YÖKSİS · co-author record: 7- i10-index
- 7
- Total citations
- 242 Top 92% in Türkiye
- Per article
- 30.2
- FWCI
- 3.88 1.00 = world average
- World top 1%
- 0
- World top 10%
- 3
Most cited articles
- The combination of thymoquinone and paclitaxel shows anti-tumor activity through the interplay with apoptosis network in triple-negative breast cancer.
- Analysis of the forward and reverse bias I V characteristics on Au PVA Zn n Si Schottky barrier diodes in the wide temperature range
- Inhibition of epithelial-mesenchymal transition in bladder cancer cells via modulation of mTOR signalling
How is this computed?
h-index and citations are computed from the citation counts of this academic’s YÖKSİS articles matched in OpenAlex (not Google Scholar, WoS or Scopus). Unmatched articles are not included. 7 articles (241 citations) tagged with this academic’s YÖK author id in co-authors’ YÖKSİS records count only towards citations, h-index and i10; article counts, percentiles and rankings use their own YÖKSİS list.
Field ranking
YÖKSİS ?-
Main field Sağlık Bilimleri Temel AlanıPoints rank #15,438/ 39,749 top 38.8% At university #197/ 411Score 16.6 journal 16.6 · OA add 0
- Article rank20,559/39,749
- Scopus rank15,163/39,749
- WoS rank14,732/39,749
- YÖKSİS20
- Scopus18
- WoS18
-
Side field Tıbbi BiyolojiPoints rank #295/ 606 top 48.7% At university #9/ 12Score 16.6 journal 16.6 · OA add 0
- Article rank359/606
- Scopus rank301/606
- WoS rank295/606
- YÖKSİS20
- Scopus18
- WoS18
Collaboration network
From the author lists of YÖKSİS publication records. Duplicate records of a work count once; institutions are co-authors’ current YÖKSİS affiliations.
- Co-authors
- 43
- With an akaturk profile
- 7
- Turkish institutions
- 3
- Co-authored works
- %95
Academic co-authors 7
- HALİT CANATAN Profesör · Erciyes Üniversitesi 13
- GÜRLER AKPINAR Profesör · Kocaeli Üniversitesi same university 2
- MEHMET SARIHAN Doktor Öğretim Üyesi · Kocaeli Üniversitesi same university 2
- MURAT KASAP Profesör · Kocaeli Üniversitesi same university 2
- MUSTAFA ÇAKIR Doktor Öğretim Üyesi · Van Yüzüncü Yıl Üniversitesi 2
- BERKAY SARAYMEN Öğretim Görevlisi (uygulamalı Birim) · Erciyes Üniversitesi 1
- SALİH ŞANLIOĞLU Profesör · Akdeniz Üniversitesi 1
National collaboration 3 institutions
Within own university2 joint works · Kocaeli Üniversitesi
- Erciyes Üniversitesi 13 works · 2 academics
- Van Yüzüncü Yıl Üniversitesi 2 works · 1 academics
- Akdeniz Üniversitesi 1 works · 1 academics
Other co-authors (incl. international) 36
KENAN İZGİ 12ÇAĞRI ŞAKALAR 5Aslıhan Arslanhan 3BENGİ SU RUMEYSA BARLAK 3Susan J. Kimber 3Esra Hilal Yüksek 2Esra Hızar 2Johann Jauch 2Melissa A. Baxter 2SEDAT SEZEN 2Adam ByronAli TuranBüşra KurtDaniel R BrisonDavid KnightDespina SoteriouDuncan MillerHALİT KARACAHuriye AksuJayne C FitzsimmonsJinpei YeJohn AplinJonathan D. HumphriesLoriana VitilloMEHMET FATİH SÖNMEZMaria V CamarasaMarie-Claire HaddockMartin J. HumphriesMaël CharpentierNicola BatesPaul WhitingSimon Borg-BartoloTristan R McKayTyson V Sharpdaniel foxlermaureen mee
Authors without an akaturk profile (international researchers, retired or former academics, students, clinicians) are grouped by name spelling; short forms such as “Gulluce M.” join the single full name they match.
Indexes and citation percentiles
?Other counts
Scopus (SJR)
- YÖKSİS rows 19
WoS (JCR)
- YÖKSİS rows 19
TR Index
- YÖKSİS rows 2 articles
Articles
Articles with YÖKSİS and OpenAlex source split; narrow by quartile or TR Index.
Journals with publications
16 journals
- Tumor Biology 4
- Cancer Genomics and Proteomics 2
- ISSN 1309-8578 1
- 3098578 1
- Anti-Cancer Agents in Medicinal Chemistry 1
- BMC Cancer 1
- European Cytokine Network 1
- Journal of Biochemical and Molecular Toxicology 1
- Journal of Biological Chemistry 1
- Journal of Cancer Research and Clinical Oncology 1
- Journal of Natural Medicines 1
- Medeniyet Medical Journal 1
- Molecular and Cellular Biochemistry 1
- Stem Cell Reports 1
- Stem Cell Research 1
- Tissue Engineering and Regenerative Medicine 1
Narrow down
Article list
- 2026 Reprogramming-driven Proteomic Shifts Mirror Bladder Cancer Progression and Reveal Biomarker Candidates Across Disease Grades. YÖKSİS SJR Q2 JCR Q2
- 2026 Conjoining cell reprogramming and mass spectrometry to identify the proteomic variations in the reprogrammed bladder cancer cells: finding cues of normalisation YÖKSİS SJR Q2 JCR Q2
- 2026 Proteomic Signatures of Cellular Reprogramming in Bladder Cancer: Insights into the Acquisition of Cancer Stem-like States and Phenotypic Plasticity YÖKSİS SJR Q2 JCR Q2
- 2022 The Active Compound Thymoquinone Alters Chondrogenic Differentiation of Human Mesenchymal Stem Cells via Modulation of Intracellular Signaling YÖKSİS TR Index SJR Q4 JCR Q2
- 2017 Current status in cancer cell reprogramming and its clinical implications. YÖKSİS SJR Q1 JCR Q2
- 2017 Long Term Exposure to Myrtucommulone-A Changes CD105 Expression and Differentiation Potential of Mesenchymal Stem Cells YÖKSİS SJR Q3 JCR Q4
- 2017 Effects of Epirubicin and Cisplatin Against 4T1 Breast Cancer Cells are Enhanced by Myrtucommulone-A YÖKSİS SJR Q2 JCR Q3
- 2016 The combination of thymoquinone and paclitaxel shows anti-tumor activity through the interplay with apoptosis network in triple-negative breast cancer YÖKSİS SJR Q1 JCR Q2
- 2016 Reprogramming bladder cancer cells for studying cancer initiation and progression YÖKSİS SJR Q1 JCR Q2
- 2016 Novel anti-cancer agent myrtucommulone-A and thymoquinone abrogate epithelial-mesenchymal transition in cancer cells mainly through the inhibition of PI3K/AKT signalling axis YÖKSİS SJR Q1 JCR Q3
- 2016 Inhibition of epithelial-mesenchymal transition in bladder cancer cells via modulation of mTOR signalling YÖKSİS SJR Q1 JCR Q2
- 2016 Integrin-Associated Focal Adhesion Kinase Protects Human Embryonic Stem Cells from Apoptosis, Detachment, and Differentiation YÖKSİS SJR Q1 JCR Q1
- 2016 Priming hMSCs with a putative anti-cancer compound, myrtucommulone-a: a way to harness hMSC cytokine expression via modulating PI3K/Akt pathway? YÖKSİS SJR Q1 JCR Q2
- 2015 Myrtucommulone-A treatment decreases pluripotency- and multipotency-associated marker expression in bladder cancer cell line HTB-9 YÖKSİS SJR Q1 JCR Q3
- 2015 Evaluation of two different adjuvants with immunogenic uroplakin 3A-derived peptide for their ability to evoke an immune response in mice YÖKSİS SJR Q2 JCR Q3
- 2015 Myrtucommulone-A Induces both Extrinsic and Intrinsic Apoptotic Pathways in Cancer Cells YÖKSİS SJR Q2 JCR Q2
- 2014 Human Embryonic Stem Cells And Microenvironment YÖKSİS OpenAlex 50.4%
- 2013 Comparative Proteomic Analysis of Supportive and Unsupportive Extracellular Matrix Substrates for Human Embryonic Stem Cell Maintenance YÖKSİS SJR Q1 JCR Q1
- 2013 Induced pluripotent stem cells and cell therapy İndüklenmiş pluripotent kök hücreler ve hücre tedavisi YÖKSİS
- 2011 Human feeder cell line for derivation and culture of hESc/hiPSc YÖKSİS SJR Q1 JCR Q1